Heidelinde Damian February 8, 2019

This concise volume is designed to cover the heterogeneous group of acquired neuromuscular disorders, from etiology to treatment. This is a valuable undertaking, but also quite an ambitious task. Today’s aging population and their inherent risks of developing diseases requiring medications with potentially adverse treatment effects like statins, cancer drugs and immune modulators, cancer with related possible paraneoplastic disorders, will make this field of neuromuscular disease even more relevant in the future.


Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App